13G Filing: Cormorant Global Healthcare Master Fund and Proteostasis Therapeutics, Inc. (PTI)

Page 6 of 8 SEC Filing

Item 1.
(a)
Name of Issuer
Proteostasis Therapeutics, Inc.
(b)
Address of Issuer’s Principal Executive Offices
200 Technology Square, 4th Floor
Cambridge, Massachusetts 02139
Item 2.
(a)
Name of Person Filing
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LLC
Bihua Chen
(b)
Address of Principal Business Office or, if none, Residence
200 Clarendon Street, 52nd Floor
Boston, MA 02116
(c)
Citizenship
Cormorant Global Healthcare Master Fund, LP – Cayman Islands
Cormorant Global Healthcare GP, LLC – Delaware
Cormorant Asset Management, LLC – Delaware
Bihua Chen – United States
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
74373B109

Follow Kineta Inc. (NASDAQ:KA)